DE60232069D1 - Formen prostataspezifischer antigene und verfahren zu deren nachweis - Google Patents

Formen prostataspezifischer antigene und verfahren zu deren nachweis

Info

Publication number
DE60232069D1
DE60232069D1 DE60232069T DE60232069T DE60232069D1 DE 60232069 D1 DE60232069 D1 DE 60232069D1 DE 60232069 T DE60232069 T DE 60232069T DE 60232069 T DE60232069 T DE 60232069T DE 60232069 D1 DE60232069 D1 DE 60232069D1
Authority
DE
Germany
Prior art keywords
prostate
forms
antigenes
providing
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60232069T
Other languages
English (en)
Inventor
Stephen D Mikolajczyk
Mohammad S Saedi
Harry G Rittenhouse
Abhay Kumar
Robert L Wolfert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Application granted granted Critical
Publication of DE60232069D1 publication Critical patent/DE60232069D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21077—Semenogelase (3.4.21.77), i.e. prostate specific antigen or PSA or kallikrein 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60232069T 2001-02-23 2002-02-22 Formen prostataspezifischer antigene und verfahren zu deren nachweis Expired - Lifetime DE60232069D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/792,692 US7288636B2 (en) 1997-04-30 2001-02-23 Forms of prostate specific antigens and methods for their detection
PCT/US2002/005424 WO2002072752A2 (en) 2001-02-23 2002-02-22 Forms of prostate specific antigens and methods for their detection

Publications (1)

Publication Number Publication Date
DE60232069D1 true DE60232069D1 (de) 2009-06-04

Family

ID=25157751

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60232069T Expired - Lifetime DE60232069D1 (de) 2001-02-23 2002-02-22 Formen prostataspezifischer antigene und verfahren zu deren nachweis

Country Status (7)

Country Link
US (1) US7288636B2 (de)
EP (1) EP1392719B1 (de)
AT (1) ATE429440T1 (de)
AU (1) AU2002306568A1 (de)
DE (1) DE60232069D1 (de)
ES (1) ES2324601T3 (de)
WO (1) WO2002072752A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7659073B2 (en) 1997-04-30 2010-02-09 Hybritech Incorporated Forms of prostate specific antigens and methods for their detection
WO2009029550A2 (en) * 2007-08-24 2009-03-05 Singulex, Inc. Highly sensitive system and methods for analysis of prostate specific antigen (psa)
US8557777B2 (en) 2010-07-09 2013-10-15 The Board Of Trustees Of The University Of Illinois Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides
WO2012006634A2 (en) * 2010-07-09 2012-01-12 The Board Of Trustees Of The University Of Illiniois Prostate specific antigen (psa) peptide therapy
US9347946B2 (en) * 2010-09-23 2016-05-24 Biocept, Inc. Methods and reagents for signal amplification
EP3563865A3 (de) 2012-05-04 2019-12-04 Pfizer Inc Prostata-assoziierte antigene und immuntherapieschemata auf impfstoffbasis
CN105929151A (zh) * 2016-06-30 2016-09-07 深圳市亚辉龙生物科技股份有限公司 前列腺特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
EP0667920B1 (de) 1992-10-29 2003-01-15 Thomas Jefferson University Methoden zur detektion von mikrometastasen bei prostata-krebs
US6103237A (en) 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
EP0725139A3 (de) 1995-02-03 1997-11-26 Bayer Corporation Rekombinantes prostat-spezifisches Antigen und seiner Verwendung als Immunoassay-Kalibrator
JP5284554B2 (ja) 1997-04-30 2013-09-11 ハイブリテック インコーポレイテッド 前立腺特異的抗原の形態およびその検出方法
US7674275B2 (en) 2006-10-05 2010-03-09 Ethicon Endo-Surgery, Inc. Suture anchor

Also Published As

Publication number Publication date
US20020058291A1 (en) 2002-05-16
EP1392719A4 (de) 2005-10-19
AU2002306568A1 (en) 2002-09-24
WO2002072752A3 (en) 2003-02-27
WO2002072752A2 (en) 2002-09-19
EP1392719A2 (de) 2004-03-03
US7288636B2 (en) 2007-10-30
ES2324601T3 (es) 2009-08-11
ATE429440T1 (de) 2009-05-15
EP1392719B1 (de) 2009-04-22

Similar Documents

Publication Publication Date Title
HK1077602A1 (en) Use of nucleic acids in preparation of a diagnostic agent for evaluating a disease condition in a patient
MXPA03003281A (es) Deteccion enzimatica no invasiva de estados asociados con la remodelacion de tejidos.
DE60020529D1 (de) Antikörper zur krebsbehandlung und -diagnose
ATE275642T1 (de) Verfahren zur diagnose von krebs
WO2005010213A3 (en) Markers for detection of gastric cancer
BRPI0411200A (pt) método de tratamento de cáncer, métodos de tratamento de paciente humano, artigo industrializado e kit de tratamento de cáncer
WO2002033116A3 (en) Nucleic acid ligands to the prostate specific membrane antigen
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
ATE477224T1 (de) Verwendung von miniatursierten vorrichtungen zur herstellung von radiomarkierten verbindungen
WO2005113831A3 (en) Biomarkers for multiple sclerosis and methods of use thereof
WO2011082345A3 (en) Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof
DE60232069D1 (de) Formen prostataspezifischer antigene und verfahren zu deren nachweis
ATE404676T1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
WO2003000117A3 (en) Detection and treatment of prostate cancer
WO2005069935A3 (en) METHODS FOR MEASURING TRANSFORMING GROWTH FACTOR BETA (TGF-β) RECEPTOR SIGNALING ACTIVITY AND USES THEREOF
RS20100249A (en) CONJUGATES AND PROCEDURES FOR THEIR PRODUCTION, AND THEIR USE FOR THE TRANSPORT OF MOLECULES THROUGH BIOLOGICAL MEMBRANE
EP1572225A4 (de) Thrombospondinfragmente und deren verwendung bei klinischen krebs-tests und der erzeugung von antikörpern und sonstigen bindungsmitteln
WO2006124866A3 (en) Free human serum ige immunoenzymetric assay and methods of use
WO2004003166A3 (en) Antibodies and uses thereof
IL159479A0 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
WO2002062300A3 (en) Cholesterol-lowering agents as treatment for psychological and cognitive disorders
NO20075698L (no) Preparater og fremgangsmater til diagnostisering og behandling av tumor
WO2003050499A3 (de) Verwendung eines markierten liganden mit spezifität für das humane cd4-molekül
DE60309879D1 (de) Verfahren zur Diagnose von Krebs
WO2003028539A3 (en) Materials and methods for the diagnosis of pediatric tumors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition